8h
News-Medical.Net on MSNAdding curcumin boosts the efficacy of bedaquiline in combating M. abscessus infectionsMycobacterium abscessus is a fast-growing, pathogenic mycobacteria that can cause lung infections, and people who have ...
But if we can’t ban pharmaceutical ads, we can at least rein them in. Policymakers can play an integral role in addressing the manipulative advertising practices rampant in the industry, while still ...
The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...
13h
Clinical Trials Arena on MSNAstraZeneca’s $1bn hypoparathyroidism drug achieves success at Phase IIIUK-based AstraZeneca’s acquired rare disease drug has met the primary endpoint in a Phase III trial in patients with chronic ...
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
GlobalData on MSN1d
Scholar Rock SMA drug shows muscle function benefitScholar Rock’s spinal muscular atrophy (SMA) therapy has shown benefit in muscle function in children under 12 in a pivotal ...
FDA-approved drugs are also often patented and subject to various laws regarding exclusivity for a given manufacturer. At the ...
A new fully automated in vivo screening system (AISS) has been developed to transform drug evaluation by enabling rapid, ...
The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.
Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...
HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results